<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"><channel><title><![CDATA[The Irreplaceables: Peer Review]]></title><description><![CDATA[What the agencies are actually doing with AI — tracked, sourced and dated. Facts first, conclusions labelled as such.]]></description><link>https://blog.irreplaceables.health/s/peer-review</link><image><url>https://substackcdn.com/image/fetch/$s_!CCZx!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ff972e0ae-6eba-45e1-bf58-53ed4714b32c_400x400.png</url><title>The Irreplaceables: Peer Review</title><link>https://blog.irreplaceables.health/s/peer-review</link></image><generator>Substack</generator><lastBuildDate>Sat, 21 Nov 2026 11:51:30 GMT</lastBuildDate><atom:link href="https://blog.irreplaceables.health/feed" rel="self" type="application/rss+xml"/><copyright><![CDATA[The Irreplaceables]]></copyright><language><![CDATA[en]]></language><webMaster><![CDATA[irreplaceables@substack.com]]></webMaster><itunes:owner><itunes:email><![CDATA[irreplaceables@substack.com]]></itunes:email><itunes:name><![CDATA[Ned Carver]]></itunes:name></itunes:owner><itunes:author><![CDATA[Ned Carver]]></itunes:author><googleplay:owner><![CDATA[irreplaceables@substack.com]]></googleplay:owner><googleplay:email><![CDATA[irreplaceables@substack.com]]></googleplay:email><googleplay:author><![CDATA[Ned Carver]]></googleplay:author><itunes:block><![CDATA[Yes]]></itunes:block><item><title><![CDATA[Peer Review // August 2, 2026]]></title><description><![CDATA[Peer Review tracks what a defined set of health communications agencies are doing with AI.]]></description><link>https://blog.irreplaceables.health/p/peer-review-august-2-2026</link><guid isPermaLink="false">https://blog.irreplaceables.health/p/peer-review-august-2-2026</guid><dc:creator><![CDATA[Ned Carver]]></dc:creator><pubDate>Mon, 03 Aug 2026 12:08:05 GMT</pubDate><enclosure url="https://substackcdn.com/image/fetch/$s_!9fbD!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<p>Peer Review tracks what a defined set of health communications agencies are doing with AI. Sourced, dated facts. Where I draw a conclusion I&#8217;ll label it &#8212; and at this stage there are very few worth drawing.</p><p>In scope: WPP&#8217;s health assets, Inizio, Omnicom Health, Real Chemistry, OPEN Health, Syneos Health and Envision. Health communications work only.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="https://substackcdn.com/image/fetch/$s_!9fbD!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="https://substackcdn.com/image/fetch/$s_!9fbD!,w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 424w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 848w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 1272w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 1456w" sizes="100vw"><img src="https://substackcdn.com/image/fetch/$s_!9fbD!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png" width="1456" height="625" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:625,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:111939,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://blog.irreplaceables.health/i/209574766?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="https://substackcdn.com/image/fetch/$s_!9fbD!,w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 424w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 848w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 1272w, https://substackcdn.com/image/fetch/$s_!9fbD!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6d66b1ba-b005-4a88-8813-8f7fecc59170_2480x1064.png 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"><button class="pencraft pc-reset pencraft icon-container restack-image buttonBase-tqxFUX" tabindex="0" type="button"><svg aria-hidden="true" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke-width="1.5" stroke="var(--color-fg-primary)" stroke-linecap="round" stroke-linejoin="round" xmlns="http://www.w3.org/2000/svg" class="icon-noB79L"><g><path d="M2.53001 7.81595C3.49179 4.73911 6.43281 2.5 9.91173 2.5C13.1684 2.5 15.9537 4.46214 17.0852 7.23684L17.6179 8.67647M17.6179 8.67647L18.5002 4.26471M17.6179 8.67647L13.6473 6.91176M17.4995 12.1841C16.5378 15.2609 13.5967 17.5 10.1178 17.5C6.86118 17.5 4.07589 15.5379 2.94432 12.7632L2.41165 11.3235M2.41165 11.3235L1.5293 15.7353M2.41165 11.3235L6.38224 13.0882"></path></g></svg></button><button class="pencraft pc-reset pencraft icon-container view-image buttonBase-tqxFUX" tabindex="0" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-maximize2 lucide-maximize-2 icon-noB79L"><polyline points="15 3 21 3 21 9"></polyline><polyline points="9 21 3 21 3 15"></polyline><line x1="21" x2="14" y1="3" y2="10"></line><line x1="3" x2="10" y1="21" y2="14"></line></svg></button></div></div></div></a></figure></div><p>The numbers on the chart match the numbers below.</p><div><hr></div><p></p><ol><li><p>January (approx) &#8212; Omnicom unveils the next generation of <a href="https://finance.yahoo.com/news/investors-may-respond-omnicom-group-140943310.html">Omni </a>at group level, integrating Interpublic assets, Acxiom identity data and autonomous agents.</p></li><li><p>21 January &#8212; Envision&#8217;s VP of AI publishes <a href="https://www.envisionpharmagroup.com/news-events/10-ai-game-changers-set-redefine-pharma-and-medical-communications-2026https://www.envisionpharmagroup.com/news-events/10-ai-game-changers-set-redefine-pharma-and-medical-communications-2026">ten AI game-changers</a> for 2026: generative content, automated literature review, congress intelligence, MLR automation, synthetic KOLs.</p></li><li><p>30 January &#8212; OPEN Health publishes on AI-accelerated <a href="https://www.openhealthgroup.com/news/30-01-2026/evidence-generation-only-faster-how-ai-and-tokenized-data-are-accelerating-rwe-without-compromising-on-scientific-rigor/">RWE </a>and the use of tokenised data.</p></li><li><p>26 February &#8212; WPP <a href="https://marketech-apac.com/a-bold-reset-wpp-scraps-holding-structure-targets-500m-in-savings-and-ai-driven-growth/https://marketech-apac.com/a-bold-reset-wpp-scraps-holding-structure-targets-500m-in-savings-and-ai-driven-growth/">ends its holding company model</a>, folding Ogilvy, VML and AKQA into four divisions, targeting &#163;500m in savings and an AI-enabled operating structure.</p></li><li><p>6 April &#8212; Omnicom Health publishes <a href="https://www.omc.com/newsroom/omnicom-health-sxsw-2026/">eight signals</a> on the future of health at SXSW.</p></li><li><p>10 April &#8212; OPEN Health <a href="https://www.openhealthgroup.com/news/10-04-2026/ai-in-market-access-from-hype-to-real-world-impact/">assesses AI readiness across HEOR</a>: strongest in structured, repeatable tasks; weakest in judgement-driven work.</p></li><li><p>14 May &#8212; Syneos <a href="https://www.syneoshealth.com/news/Syneos-Health-Expands-Strategic-AI-Partnerships-to-Advance-Commercial-Precision-Performancehttps://www.syneoshealth.com/news/Syneos-Health-Expands-Strategic-AI-Partnerships-to-Advance-Commercial-Precision-Performance">expands its AI partnerships</a> to include Sageforce AI-powered field teams &#8212; AI MSLs, field reimbursement managers, nurse navigators, virtual sales representatives &#8212; and causaLens causal-AI agents.</p></li><li><p>21 May &#8212; <a href="https://www.fiercepharma.com/marketing/inside-agency-view-ogilvy-health-ais-light-speed-nano-influencers-and-rise-ria">Ogilvy Health goes on record</a> about its AI adoption pace and its Ria tool.</p></li><li><p>Mid-2026 (approx) &#8212; <a href="https://www.mmm-online.com/companydetail/omnicom-health-medical-communications-agency-100-2026/https://www.mmm-online.com/companydetail/omnicom-health-medical-communications-agency-100-2026/">Omnicom Health Medical Communications</a> debuts as a roll-up of ten medcomms agencies: estimated $360m revenue, 1,450 staff.</p></li><li><p>13 July &#8212; Envision publishes a whitepaper on <a href="https://www.envisionpharmagroup.com/news-events/how-to-accelerate-strategic-decision-making-in-biopharma/">AI-simulated advisory boards</a>.</p></li><li><p>14 July &#8212; Real Chemistry launches <a href="https://www.businesswire.com/news/home/20260714896757/en/Real-Chemistry-Launches-Real-Chemistry-ANATOMI-an-AI-Ecosystem-Purpose-Built-for-Healthcare-Commercialization">ANATOMI</a>, an AI ecosystem covering the commercialisation lifecycle, including a publications workflow.</p></li><li><p>28 July &#8212; Inizio Engage launches <a href="https://www.prnewswire.com/news-releases/inizio-launches-connected-insights-to-transform-global-medical-information-302836532.htmlhttps://www.prnewswire.com/news-releases/inizio-launches-connected-insights-to-transform-global-medical-information-302836532.html">Connected Insights</a>, applying AI to medical information interactions across 20+ languages.</p></li></ol><p><strong>Before 2026</strong></p><p>A. July 2024 &#8212; Envision launched <a href="https://www.envisionpharmagroup.com/news-events/envision-pharma-group-launches-4sight-drive-ai-and-technology-performance-healthcare">4Sight</a>.</p><p>B. August 2024 &#8212; Syneos appointed a dedicated <a href="https://www.prweek.com/article/1885503/syneos-health-us-pr-appoints-matthew-snodgrass-ai-innovation-lead">AI innovation lead</a> in its US PR practice.</p><p>C. March 2025 &#8212; Inizio Medical launched <a href="https://inizio.com/insights/inizio-medical-launches-ion-ai-to-transform-medical-affairs-capabilities/">iON AI</a>.</p><p><em>One observation, offered as no more than that: the tasks these products target are consistent across agencies &#8212; drafting, summarising, reference checking, evidence synthesis.</em></p><p><em>What the record does not contain: any published evidence of traction. No renewals, client wins or revenue attributed to any of these tools. Announcements are not adoption, and I won&#8217;t treat them as such. Nor does a launch date tell you whether the thing works, or whether the acquisition behind it went well.</em></p><p><em>Corrections and additions welcome &#8212; particularly from anyone who has used these tools rather than read about them. Reply and tell me.</em></p><p><em>&#8212; Ned</em></p><p><em>Follow the conversation: #IrreplaceablesHealth</em></p>]]></content:encoded></item></channel></rss>